197.60
前日終値:
$202.71
開ける:
$199.87
24時間の取引高:
2.83M
Relative Volume:
1.66
時価総額:
$23.79B
収益:
$5.94B
当期純損益:
$661.30M
株価収益率:
37.45
EPS:
5.2762
ネットキャッシュフロー:
$999.40M
1週間 パフォーマンス:
+9.15%
1か月 パフォーマンス:
-12.94%
6か月 パフォーマンス:
-17.54%
1年 パフォーマンス:
-21.90%
Equifax Inc Stock (EFX) Company Profile
Compare EFX vs VRSK, BAH, FCN, HURN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EFX
Equifax Inc
|
197.60 | 24.41B | 5.94B | 661.30M | 999.40M | 5.2762 |
|
VRSK
Verisk Analytics Inc
|
173.77 | 23.62B | 3.03B | 914.60M | 1.12B | 6.5505 |
|
BAH
Booz Allen Hamilton Holding Corp
|
79.79 | 10.85B | 11.78B | 870.25M | 844.17M | 6.70 |
|
FCN
Fti Consulting Inc
|
156.81 | 5.35B | 3.73B | 312.01M | 434.78M | 8.70 |
|
HURN
Huron Consulting Group Inc
|
131.11 | 2.51B | 1.47B | 85.47M | 106.27M | 4.60 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-13 | 開始されました | Oppenheimer | Outperform |
| 2025-10-01 | 開始されました | Seaport Research Partners | Neutral |
| 2025-07-10 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-06-23 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-04-10 | 再開されました | BofA Securities | Buy |
| 2025-04-04 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-03-20 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-14 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
| 2025-02-11 | ダウングレード | Argus | Buy → Hold |
| 2024-12-16 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-12 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-10-01 | 開始されました | UBS | Buy |
| 2024-09-19 | アップグレード | Exane BNP Paribas | Underperform → Neutral |
| 2024-08-13 | 開始されました | Wells Fargo | Overweight |
| 2024-07-09 | 開始されました | Wolfe Research | Outperform |
| 2024-02-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2024-01-11 | ダウングレード | Redburn Atlantic | Buy → Neutral |
| 2024-01-08 | アップグレード | BofA Securities | Underperform → Buy |
| 2024-01-04 | 繰り返されました | Needham | Buy |
| 2023-12-19 | 開始されました | Oppenheimer | Outperform |
| 2023-12-18 | アップグレード | Jefferies | Hold → Buy |
| 2023-12-15 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-12-08 | アップグレード | Deutsche Bank | Hold → Buy |
| 2023-11-20 | 開始されました | Citigroup | Buy |
| 2023-07-24 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-01-06 | 開始されました | Exane BNP Paribas | Underperform |
| 2022-11-15 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2022-10-21 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-10-19 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-15 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-07-13 | 開始されました | Wells Fargo | Equal Weight |
| 2022-04-21 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-03-30 | 開始されました | Deutsche Bank | Hold |
| 2022-03-11 | 再開されました | BofA Securities | Neutral |
| 2022-01-31 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-01-27 | アップグレード | Truist | Hold → Buy |
| 2022-01-24 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-01-05 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-22 | アップグレード | Argus | Hold → Buy |
| 2021-10-15 | 再開されました | Evercore ISI | Outperform |
| 2021-07-23 | 繰り返されました | Goldman | Neutral |
| 2021-07-08 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2020-12-15 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2020-12-11 | アップグレード | Stifel | Hold → Buy |
| 2020-12-08 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-10-07 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2020-10-06 | 開始されました | Needham | Buy |
| 2020-07-10 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
| 2020-06-09 | ダウングレード | SunTrust | Buy → Hold |
| 2020-05-15 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2020-04-06 | ダウングレード | Argus | Buy → Hold |
| 2020-03-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-03-02 | アップグレード | Exane BNP Paribas | Underperform → Outperform |
| 2020-01-17 | アップグレード | Argus | Hold → Buy |
| 2019-11-22 | 開始されました | Jefferies | Buy |
| 2019-03-15 | 開始されました | Exane BNP Paribas | Underperform |
| 2019-02-05 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2018-12-07 | 再開されました | Credit Suisse | Outperform |
| 2018-10-26 | 繰り返されました | Barclays | Equal Weight |
| 2018-10-23 | 再開されました | BofA/Merrill | Underperform |
| 2018-04-10 | 開始されました | BofA/Merrill | Underperform |
| 2017-12-14 | ダウングレード | Barclays | Overweight → Equal Weight |
すべてを表示
Equifax Inc (EFX) 最新ニュース
Equifax (EFX) Valuation Check After Earnings Beat, 2026 Outlook, Buybacks And New Growth Initiatives - simplywall.st
Here's Why You Should Hold Equifax Stock in Your Portfolio Now - Yahoo Finance
Equifax's Q4 Earnings Call: Our Top 5 Analyst Questions - Finviz
Madison Asset Management LLC Increases Stock Position in Equifax, Inc. $EFX - MarketBeat
Equifax, Inc. $EFX Shares Bought by Oppenheimer Asset Management Inc. - MarketBeat
Why (EFX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
19,038 Shares in Equifax, Inc. $EFX Purchased by Katamaran Capital LLP - MarketBeat
EFX Price Target Lowered to $208 by Goldman Sachs | EFX Stock Ne - GuruFocus
Equifax (EFX) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Needham & Company LLC Lifts Earnings Estimates for Equifax - MarketBeat
Equifax accused of price gouging Medicaid programs - WSAW
Gen Digital Links AI Agent Security With Equifax Powered Consumer Protection - Yahoo Finance
Equifax Inc. (EFX) Unveils Credit Card Origination and Employment Insight Solutions - Finviz
Envestnet Asset Management Inc. Raises Stake in Equifax, Inc. $EFX - MarketBeat
Equifax’s AI Push, Cloud Shift And Buybacks Might Change The Case For Investing In EFX - simplywall.st
Equifax providing a new six-year credit-monitoring service to victims of 2017 data breach - WGAL
Gen Digital, Equifax Partner To Offer Tools For Managing Finances And Online Security - Crowdfund Insider
Equifax Fell 6% Last Week. Here’s Where the Stock Could Head in 2026 - TIKR.com
Goldman Sachs Adjusts Equifax Price Target to $208 From $235, Maintains Neutral Rating - marketscreener.com
Equifax Announces Earnings Release Date and Conference Call for Fourth Quarter 2025 Results - Eastern Progress
Research Alert: CFRA Lowers Rating On Shares Of Equifax Inc. To Hold From Buy - 富途牛牛
Senators accuse Equifax of price gouging - KVUE
JPMorgan Chase & Co. Has Lowered Expectations for Equifax (NYSE:EFX) Stock Price - MarketBeat
JP Morgan Lowers Price Target for EFX, Maintains Overweight Rati - GuruFocus
EFX: Stifel Maintains Buy Rating, Lowers Price Target to $235 | - GuruFocus
Senators investigate Equifax's role in Medicaid verification - NonStop Local KHQ
Royal Bank Of Canada Issues Pessimistic Forecast for Equifax (NYSE:EFX) Stock Price - MarketBeat
Equifax (EFX) Valuation Reassessed After Recent Share Price Pullback - Yahoo Finance
Equifax (EFX) Maintains Equal-Weight, Price Target Lowered by Ba - GuruFocus
EFX: RBC Capital Maintains Rating and Lowers Price Target | EFX Stock News - GuruFocus
Senators Accuse Equifax of ‘Price-Gouging’ Medicaid Programs - The New York Times
Getting a new Bilt or Apple Card soon? How to maximize your credit score during a transition - CNBC
EFX Analyst Update: Morgan Stanley Lowers Price Target to $244 | - GuruFocus
EFX: Wells Fargo Lowers Price Target but Maintains Overweight Ra - GuruFocus
Wells Fargo & Company Has Lowered Expectations for Equifax (NYSE:EFX) Stock Price - MarketBeat
Wells Fargo Adjusts Price Target on Equifax to $240 From $265, Maintains Overweight Rating - marketscreener.com
Baird Adjusts Price Target on Equifax to $250 From $289, Maintains Outperform Rating - marketscreener.com
These Analysts Cut Their Forecasts On Equifax After Q4 Earnings - Benzinga
Barclays Adjusts Price Target on Equifax to $215 From $240, Maintains Equalweight Rating - marketscreener.com
JPMorgan Adjusts Price Target on Equifax to $230 From $260, Maintains Overweight Rating - marketscreener.com
Equifax (EFX) Faces Target Price Adjustment Amidst Maintained Bu - GuruFocus
RBC Cuts Price Target on Equifax to $222 From $250, Keeps Outperform Rating - marketscreener.com
Needham & Company LLC Lowers Equifax (NYSE:EFX) Price Target to $265.00 - MarketBeat
Equifax Inc. (NYSE: EFX) Q4 2025 earnings call transcript - MSN
Equifax Inc. (NYSE:EFX) Q4 2025 Earnings Call Transcript - Insider Monkey
Senators Demand Answers on Equifax Plan to 'Profiteer' Off GOP Medicaid Work Requirements - Common Dreams
Breaking Down Equifax: 5 Analysts Share Their Views - Benzinga
Equifax: Resilient Data Moat and FICO-Driven Upside Undervalued, Supporting Buy Rating - TipRanks
Morgan Stanley Lowers Price Target on Equifax to $244 From $269, Keeps Overweight Rating - marketscreener.com
Equifax (NYSE:EFX) Sets New 1-Year LowWhat's Next? - MarketBeat
Senators probe Equifax over plans to profit from Medicaid and SNAP work requirements - Nation of Change
Equifax Inc (EFX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):